Menu

Search

  |   Business

Menu

  |   Business

Search

US HIV/AIDS Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers

Dublin, Feb. 26, 2018 -- The "US HIV/AIDS Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers" report has been added to ResearchAndMarkets.com's offering

This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

  • Hospitals
  • Commercial/Private Laboratories
  • Blood Banks
  • Physician Offices
  • Public Health Laboratories

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Key Topics Covered:

I. Introduction

II. AIDS/HIV Worldwide Market and Technology Overview

A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. USA: Market Size, Growth and Major Suppliers'

Sales and Market Shares

IV. Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized

Testing Markets

1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

V. Potential Market Entry Barriers and Risks


A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix/Erba
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatch/Leica
  • Life Technology
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

For more information about this report visit https://www.researchandmarkets.com/research/x6489j/us_hivaids?w=12



CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Infectious Disease Testing

Primary Logo

  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.